Joachim Schessl1, Wolfram Kress, Benedikt Schoser. 1. Friedrich-Baur-Institute, Department of Neurology, Ludwig-Maximilians University of Munich, Germany. joachim.schessl@med.uni-muenchen.de
Abstract
INTRODUCTION: Mutations in the anoctamin 5 gene (ANO5) have been recently identified.They cause limb girdle muscular dystrophy (LGMD2L) and Miyoshi muscular dystrophy. METHODS: Clinical findings of four unrelated patients are reviewed. Mutation detection was performed by direct sequencing of the ANO5 exons. RESULTS: We identified four novel mutations in the ANO5 gene. In one patient, a novel homozygous mutation (c.1965G>C). In three patients, the recurrent heterozygous exon 5 c.191dupA mutation is combined with other variants to form a compound heterozygous state: in two cases, novel splice site mutations in intron 5 (c.295-1G>A) and in intron 14 (c.1407+5G>A), and in one case, a novel missense mutation in exon 4 (c.172C>T). CONCLUSIONS: The cases reported here should help to better understand the important role of mutation screening in the ANO5 gene in patients with adult onset muscular dystrophy and very high CK levels.
INTRODUCTION: Mutations in the anoctamin 5 gene (ANO5) have been recently identified.They cause limb girdle muscular dystrophy (LGMD2L) and Miyoshi muscular dystrophy. METHODS: Clinical findings of four unrelated patients are reviewed. Mutation detection was performed by direct sequencing of the ANO5 exons. RESULTS: We identified four novel mutations in the ANO5 gene. In one patient, a novel homozygous mutation (c.1965G>C). In three patients, the recurrent heterozygous exon 5 c.191dupA mutation is combined with other variants to form a compound heterozygous state: in two cases, novel splice site mutations in intron 5 (c.295-1G>A) and in intron 14 (c.1407+5G>A), and in one case, a novel missense mutation in exon 4 (c.172C>T). CONCLUSIONS: The cases reported here should help to better understand the important role of mutation screening in the ANO5 gene in patients with adult onset muscular dystrophy and very high CK levels.
Authors: Caterina Marconi; Paolo Brunamonti Binello; Giovanni Badiali; Emanuela Caci; Roberto Cusano; Joseph Garibaldi; Tommaso Pippucci; Alberto Merlini; Claudio Marchetti; Kerry J Rhoden; Luis J V Galietta; Faustina Lalatta; Paolo Balbi; Marco Seri Journal: Eur J Hum Genet Date: 2012-10-10 Impact factor: 4.246
Authors: Jing Xu; Mona El Refaey; Li Xu; Lixia Zhao; Yandi Gao; Kyle Floyd; Tallib Karaze; Paul M L Janssen; Renzhi Han Journal: Skelet Muscle Date: 2015-12-21 Impact factor: 4.912
Authors: Tim Rolvien; Osman Avci; Simon von Kroge; Till Koehne; Stefan Selbert; Stephan Sonntag; Doron Shmerling; Uwe Kornak; Ralf Oheim; Michael Amling; Thorsten Schinke; Timur Alexander Yorgan Journal: Bone Rep Date: 2020-05-14
Authors: André M S Silva; Antônio R Coimbra-Neto; Paulo Victor S Souza; Pablo B Winckler; Marcus V M Gonçalves; Eduardo B U Cavalcanti; Alzira A D S Carvalho; Cláudia F D R Sobreira; Clara G Camelo; Rodrigo D H Mendonça; Eduardo D P Estephan; Umbertina C Reed; Marcela C Machado-Costa; Mario E T Dourado-Junior; Vanessa C Pereira; Marcelo M Cruzeiro; Paulo V P Helito; Laís U Aivazoglou; Leonardo V D Camargo; Hudson H Gomes; Amaro J S D Camargo; Wladimir B V D R Pinto; Bruno M L Badia; Luiz H Libardi; Mario T Yanagiura; Acary S B Oliveira; Anamarli Nucci; Jonas A M Saute; Marcondes C França-Junior; Edmar Zanoteli Journal: Ann Clin Transl Neurol Date: 2019-06-11 Impact factor: 4.511
Authors: T V Andreeva; T V Tyazhelova; V N Rykalina; F E Gusev; A Yu Goltsov; O I Zolotareva; M P Aliseichik; T A Borodina; A P Grigorenko; D A Reshetov; E K Ginter; S S Amelina; R A Zinchenko; E I Rogaev Journal: Sci Rep Date: 2016-05-24 Impact factor: 4.379